儿科肝病学的不断变化的格局:关键更新和未来方向
Paul Lu1, Nadia Ovchinsky2, Dana Goldner2
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Hassenfeld Children's Hospital, New York University Langone Hospitals.
Current opinion in pediatrics
|August 18, 2025
概括
最近的儿科肝病学进展包括重新定义的代谢功能障碍相关的脂肪性肝病 (MASLD) 和胆固醇性疾病的新疗法. 这些创新改善了患有肝病的儿童的护理.
科学领域:
- 儿科肝病学 儿科肝病学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 儿科肝病需要更新的诊断和治疗策略.
- 分子和免疫学见解对于推进临床实践至关重要.
研究的目的:
- 审查儿科肝病学近期的进展.
- 突出新诊断标准,疗法和分子洞察力.
- 讨论对临床实践和未来研究的影响.
主要方法:
- 对儿科肝病学最新文献的综述.
- 分析新出现的诊断标准和治疗选择.
- 对儿童肝脏疾病的分子洞察力的检查.
主要成果:
- 代谢功能障碍相关的脂肪性肝病 (MASLD) 是非酒精性脂肪性肝病 (NAFLD) 的新术语.
- 已确定激活的T细胞肝炎是儿科急性肝衰竭的关键因素.
- 皮质胆汁酸载体 (IBAT) 抑制剂在儿科胆固醇性疾病中表现有前途,改善生长和生活质量.
结论:
- 不断发展的疾病分类和新型疗法正在个性化儿科肝病护理.
- 基因和免疫学分析越来越重要.
- 需要进一步的研究来证实新治疗方法的长期益处.
相关概念视频
Diseases of the Liver and Gallbladder
976
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
976
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Esophageal Varices-II: Clinical Features and Management
139
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
139
Hepatic Drug Excretion: Influencing Factors
216
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
216
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
201
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
201
Hepatic Drug Clearance: Role of Transporters
100
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
100


